News & Information
At Memorial Sloan Kettering, our leading edge research is constantly advancing what we know about cancer and new discoveries are improving care for patients here, and all over the world. In News and Information, you will find information about our groundbreaking work and the dedicated professionals who make it all happen.
For Journalists
Connect with us to reach MSK experts for media inquiries, source story ideas and download MSK digital assets.
Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the number two hospital for cancer care in the nation by U.S. News & World Report in its annual Best Hospitals listing.
During the height of the COVID-19 pandemic, when the constant sound of sirens filled the streets of New York City, Memorial Sloan Kettering Deputy Chief Nurse Kevin Browne found himself in a somewhat unfamiliar place: in the back of an ambulance headed to MSK—this time as a patient.
In the News
The United States Preventive Services Task Force released updated draft recommendations on colorectal cancer screening which, among other things, call for screening for the general population to begin at age 45.
Chief of the Melanoma Service Michael Postow, MD, Medical Oncologist Nitya Raj, MD, and Assistant Attending Triparna Sen, PhD were included on this year’s list.
There is a significant threat to pediatric cancer research stemming from COVID-19's impact on philanthropy. That message is shared by MSK’s Chair of the Department of Pediatrics, Andrew Kung, MD, PhD, in a recent op-ed published in U.S. News & World Report.
Stay Connected with MSK
News Releases
Neuro-oncologist and renowned physician-scientist Ingo Mellinghoff will lead MSK’s distinguished Department of Neurology after previously serving as Acting Co-Chair.
Dr. Thompson and MSK are being recognized with this prestigious award for leadership during the ongoing COVID-19 pandemic.
Four MSK researchers out of 15 winners nationwide were named recipients of the prestigious award. They will each receive a grant of up to $600,000 per year for seven years to support their research in cancer.
Media Coverage
Cancer health disparities persist. Barriers in access to care, noninclusive research, unequal use of preventive measures like cancer screening, and findings of different treatment and worse outcomes even for people with similar disease show there’s much work to be done. MSK’s Carol Brown is quoted.
Thursday, October 29, 2020
An influential federal task force composed of experts in prevention and evidence-based medicine plans to change its guidelines on colorectal cancer screenings to recommend that adults begin getting screened at 45 years old, instead of 50. MSK’s Robin Mendelsohn is quoted.
Tuesday, October 27, 2020
The final recommendation by the U.S. Preventive Services Task Force would lower the age for screening by five years and require many insurers to cover the testing. MSK’s Robin Mendelsohn is quoted.
Tuesday, October 27, 2020
MSK News
Learn about diversity and inclusion at Memorial Sloan Kettering, as people from across MSK share their insights and personal experiences.
MSK experts acted quickly to understand the possible effects of COVID-19 on cancer patients and drew on vast experience to explore new treatments.
Learn about MSK’s Adolescent and Young Adult program, which is uniquely positioned to help patients like Danielle Leventhal.
2019 Annual Report: It Starts with One
A unique program at MSK Kids is dedicated to finding a cure for every child with cancer.
Researchers in the Sloan Kettering Institute conducted a far-reaching analysis of single cells that is changing how we think about development.
Liquid biopsies are shedding light on cancer DNA that’s hiding out in the bloodstream. MSK-ACCESS is one such test that took a big leap forward in 2019.